Back to Agenda
Health Economics of Future Therapeutic Concepts
Session Chair(s)
Annette Mollet, PharmD, PhD, MSc
Managing Director, Head Education and Training
ECPM, University of Basel, Switzerland
Health systems throughout the world are faced with demands for additional services and rising costs. Health care decision makers need to identify efficient medical strategies and to choose the right interventions to maximise the achievable benefits for the patient within the available budgets. The concept of personalised medicine not only promises to enhance the life of patients and to increase the quality of clinical practice and targeted care pathways, but also to lower overall healthcare costs through early-detection, prevention, accurate risk assessments and efficiencies in care delivery. In this session, the view and impact of both the pharmaceutical industry and the health care insurance are introduced. In addition, current cases from an EBE-EFPIA study comparing different European countries will highlight the value of personalised medicine and the access for patients.
Speaker(s)
The Rationale for Personalised Health Care
Guido Papa
F.Hoffmann - La Roche, Switzerland
Head, Pricing & Market Access Excellence
The Case for the Value of Personalised Medicine – A European Perspective
Eelko den Breejen
F. Hoffmann-La Roche, Switzerland
International Health Policy Leader
How Can We Afford Personalised Health Care – The Payer’s View
Thomas D. Szucs, DrMed, MBA, MPH
University of Basel, ECPM, Switzerland
Have an account?